Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/26/2026 | Q4 | $813.5M | -- | -- | $0.26 | -- |
| 11/06/2025 | Q3 | $729.9M | $740.4M | $0.09 | $0.22 | -$0.12 |
| 07/31/2025 | Q2 | $692.8M | $703.6M | -$0.02 | $0.16 | -$0.18 |
| 05/08/2025 | Q1 | $680.9M | $651.7M | -$0.03 | $0.15 | -$0.18 |
| 02/27/2025 | Q4 | $753.3M | $788.7M | $0.03 | $0.24 | -$0.21 |
| 11/07/2024 | Q3 | $701.8M | $710.5M | $0.03 | $0.21 | -$0.18 |
| 08/01/2024 | Q2 | $668.7M | $672.2M | -$0.03 | $0.18 | -$0.20 |
| 05/01/2024 | Q1 | $619.5M | $668.2M | -$0.01 | $0.13 | -$0.14 |
| 02/27/2024 | Q4 | $680.7M | $650.7M | $0.01 | $0.27 | -$0.26 |
| 11/02/2023 | Q3 | -- | $614.2M | $0.01 | -- | -- |
| 08/08/2023 | Q2 | -- | $632.3M | -$0.03 | -- | -- |
| 05/09/2023 | Q1 | -- | $629.8M | $0.00 | -- | -- |
| 03/02/2023 | Q4 | -- | $718.2M | -$0.11 | -- | -- |
| 11/03/2022 | Q3 | -- | $668.8M | $0.08 | -- | -- |
| 08/04/2022 | Q2 | -- | $670.2M | $0.04 | -- | -- |
| 05/10/2022 | Q1 | -- | $639.6M | $0.04 | -- | -- |
| 03/08/2022 | Q4 | -- | $324.2M | $0.01 | -- | -- |
| 11/09/2021 | Q3 | -- | $293.1M | -$0.03 | -- | -- |
| 08/04/2021 | Q2 | -- | $209.6M | $0.22 | -- | -- |
| 03/31/2021 | Q1 | -- | $305.1M | $0.01 | -- | -- |
| 12/31/2020 | Q4 | -- | $313.1M | $0.30 | -- | -- |
| 09/30/2020 | Q3 | -- | $228.1M | $0.24 | -- | -- |
| 06/30/2020 | Q2 | -- | $266.7M | -$0.06 | -- | -- |
| 03/31/2020 | Q1 | -- | $335.2M | -$0.03 | -- | -- |
| 12/31/2019 | Q4 | -- | $382M | -$0.15 | -- | -- |
| 09/30/2019 | Q3 | -- | $342.9M | -$0.07 | -- | -- |
| 06/30/2019 | Q2 | -- | $362.1M | $0.01 | -- | -- |
| 03/31/2019 | Q1 | -- | $328.8M | -$0.04 | -- | -- |
| 12/31/2018 | Q4 | -- | $393.7M | -$1.46 | -- | -- |
| 09/30/2018 | Q3 | -- | $375.8M | -$0.32 | -- | -- |
| 06/30/2018 | Q2 | -- | $379.7M | $0.02 | -- | -- |
| 03/31/2018 | Q1 | -- | $327M | -$0.56 | -- | -- |
| 12/31/2017 | Q4 | -- | $402.7M | $3.39 | -- | -- |
| 09/30/2017 | Q3 | -- | $375.8M | $0.24 | -- | -- |
| 06/30/2017 | Q2 | -- | $390.5M | $0.14 | -- | -- |
| 03/31/2017 | Q1 | -- | $344.7M | -$0.21 | -- | -- |
| 12/31/2016 | Q4 | -- | $390.4M | $0.17 | -- | -- |
| 09/30/2016 | Q3 | -- | $349.3M | -$0.62 | -- | -- |
| 06/30/2016 | Q2 | -- | $337M | $0.02 | -- | -- |
| 03/31/2016 | Q1 | -- | $309M | -$0.47 | -- | -- |
| 12/31/2015 | Q4 | -- | $359M | -$0.52 | -- | -- |
Stagwell, Inc. reported $740.4M worth of top line sales in its most recent quarter.
Stagwell, Inc. announced earnings per share of $0.09 which represents a miss of analyst forecast a $0.22 per share.
Stagwell, Inc. reported $225.2M that represents $0.87 per share over the last quarter.
Stagwell, Inc.'s earnings are forecast to grow from $0.02 per share to $0.77 per share next year representing an increase of 4008.97%.
Stagwell, Inc.'s next earnings date is February 26, 2026.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.